CAS: 558447-26-0
Mavorixafor
CAS:558447-26-0
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of …
Formula:
C21H27N5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
349.47
Ref: TM-TQ0174
1mg | 69.00 € | |
2mg | 90.00 € | |
5mg | 150.00 € | |
10mg | 216.00 € | |
25mg | 387.00 € | |
50mg | 575.00 € | |
100mg | 816.00 € | |
1ml*10 (DMSO) | 244.00 € |
Estimated delivery in United States, on Monday 13 May 2024
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
Purity:
97.0%
Molecular weight:
349.48199462890625
Ref: 10-F229693
250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is an activated molecule that has been shown to be effective in the treatment …
Formula:
C21H27N5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
349.48 g/mol
Ref: 3D-IXA44726
1mg | 68.00 € | |
2mg | 108.00 € | |
5mg | 150.00 € | |
10mg | 216.00 € | |
25mg | 352.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024